Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
J

Jayamas Medica Industri TBK PT
IDX:OMED

Watchlist Manager
Jayamas Medica Industri TBK PT
IDX:OMED
Watchlist
Price: 214 IDR -0.93% Market Closed
Market Cap: Rp5.8T
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-
5Y
-
10Y
-
Investing Cash Flow
+
3Y
-
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-
10Y
-

Cash Flow Statement
Jayamas Medica Industri TBK PT

Rotate your device to view
Cash Flow Statement
Currency: IDR
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Cash Taxes Paid
(135 081)
(132 656)
(146 413)
(163 259)
(76 907)
(64 943)
(15 608)
(16 870)
(8 513)
(14 101)
(72 042)
(68 872)
Cash Interest Paid
(16 952)
(16 947)
(25 291)
(25 421)
(16 957)
(21 128)
(17 272)
(17 314)
(17 449)
(13 391)
(17 799)
(16 226)
Change in Working Capital
(219 769)
(231 549)
(333 642)
(381 601)
(251 415)
(250 436)
(215 957)
(227 772)
(281 266)
(299 803)
(297 648)
(316 474)
Cash from Operating Activities
92 617
N/A
(36 795)
N/A
(25 608)
+30%
68 627
N/A
134 354
+96%
309 431
+130%
410 472
+33%
393 866
-4%
351 568
-11%
402 935
+15%
351 971
-13%
348 940
-1%
Investing Cash Flow
Capital Expenditures
(75 371)
(91 373)
(146 675)
(181 611)
(156 442)
(160 036)
(127 031)
(107 080)
(102 342)
(90 389)
(84 166)
(88 698)
Other Items
(419 729)
241 766
167 061
159 412
421 035
(68 088)
(47 353)
(29 074)
(61 808)
(102 591)
(73 808)
(91 720)
Cash from Investing Activities
(495 100)
N/A
150 393
N/A
20 386
-86%
(22 199)
N/A
264 594
N/A
(228 124)
N/A
(174 384)
+24%
(136 155)
+22%
(164 151)
-21%
(192 980)
-18%
(157 974)
+18%
(180 418)
-14%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
(1 843)
(5 990)
Net Issuance of Debt
744 236
753 992
753 174
753 575
(25 307)
(35 064)
(34 773)
(37 583)
(17 265)
(19 576)
(179 514)
24
Cash Paid for Dividends
(250 000)
0
(335 777)
(335 777)
(85 777)
0
0
(77 929)
(77 929)
0
0
(96 553)
Other
(750)
0
(245)
(245)
505
0
0
0
0
0
0
(4 000)
Cash from Financing Activities
493 486
N/A
503 242
+2%
417 152
-17%
417 554
+0%
(110 578)
N/A
(120 336)
-9%
(34 773)
+71%
(115 512)
-232%
(95 195)
+18%
(97 506)
-2%
(259 287)
-166%
(106 518)
+59%
Change in Cash
Effect of Foreign Exchange Rates
6 704
382
(2 347)
2 719
1 654
7 504
17 748
(4 174)
11 911
23 829
9 584
37 383
Net Change in Cash
97 708
N/A
617 221
+532%
409 582
-34%
466 700
+14%
290 023
-38%
(31 525)
N/A
219 063
N/A
138 025
-37%
104 133
-25%
136 278
+31%
(55 706)
N/A
99 388
N/A
Free Cash Flow
Free Cash Flow
17 247
N/A
(128 169)
N/A
(172 284)
-34%
(112 984)
+34%
(22 087)
+80%
149 396
N/A
283 441
+90%
286 786
+1%
249 225
-13%
312 546
+25%
267 805
-14%
260 242
-3%

See Also

Summary
OMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
OMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OMED stock valuation using valuation multiples.
Wall Street Estimates
OMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.